Review the Learning resources on writing policy briefs.
Immediate access to the full model answer, formatted citations, and rubric breakdown.
Have this question answered from scratch according to your specific instructions and deadline.
Order on TutorsGallery →Review the Learning resources on writing policy briefs.
In-depth study guidance and analytical solution covering AG D1.
Immediate access to the full model answer, formatted citations, and rubric breakdown.
Have this question answered from scratch according to your specific instructions and deadline.
Order on TutorsGallery →Full assignment prompt and step-by-step guidance are included in the downloadable solution file.
In-depth study guidance and analytical solution covering AG D2.
Immediate access to the full model answer, formatted citations, and rubric breakdown.
Have this question answered from scratch according to your specific instructions and deadline.
Order on TutorsGallery →Full assignment prompt and step-by-step guidance are included in the downloadable solution file.
In-depth study guidance and analytical solution covering discussion.
Immediate access to the full model answer, formatted citations, and rubric breakdown.
Have this question answered from scratch according to your specific instructions and deadline.
Order on TutorsGallery →Full assignment prompt and step-by-step guidance are included in the downloadable solution file.
please write discussion post based on a 24 year old who is 8 weeks pregnant – ## NUR514CLdiscussion1.docx **## NUR514CLdiscussion1.docx**  
## image1.png
## image2.png
**## NUR514CLdiscussion1.docx**
## image1.png
## image2.png
In-depth study guidance and analytical solution covering see below.
Immediate access to the full model answer, formatted citations, and rubric breakdown.
Have this question answered from scratch according to your specific instructions and deadline.
Order on TutorsGallery →Full assignment prompt and step-by-step guidance are included in the downloadable solution file.
– ## AppendixGIndividualEvidenceSummary.docx – AppendixH.docx – AppendixFNonresearchEvidenceAppraisal.docx – AppendixEResearchEvidenceAppraisal.docx **## AppendixGIndividualEvidenceSummary.docx** Johns Hopkins Evidence-Based Practice Model for Nursing and Healthcare Professionals Individual Evidence…
Immediate access to the full model answer, formatted citations, and rubric breakdown.
Have this question answered from scratch according to your specific instructions and deadline.
Order on TutorsGallery →– ## AppendixGIndividualEvidenceSummary.docx
– AppendixH.docx
– AppendixFNonresearchEvidenceAppraisal.docx
– AppendixEResearchEvidenceAppraisal.docx
**## AppendixGIndividualEvidenceSummary.docx**
Johns Hopkins Evidence-Based Practice Model for Nursing and Healthcare Professionals
Individual Evidence Summary Tool
Appendix G
Johns Hopkins Nursing Evidence-Based Practice
Individual Evidence Summary Tool (Appendix G)
| | | | | | | | | | | |
| — | — | — | — | — | — | — | — | — | — | — |
| ## **EBP Question:** |
| ## **Reviewer name(s)** | ## **Article number** | ## **Author, date, and title** | ## **Type of evidence** | ## **Population, size, and setting** | ## **Intervention** | ## **Findings that help answer the EBP question** | ## **Measures used** | ## **Limitations** | ## **Evidence level and quality** | ## **Notes to team** |
| | | | | | | | | | | |
| | | | | | | | | | | |
| | | | | | | | | | | |
| | | | | | | | | | | |
| | | | | | | | | | | |
| | | | | | | | | | | |
| | | | | | | | | | | |
**Directions for use of the Individual Evidence Summary Tool**
**Purpose:** Use this form to document and collate the results of the review and appraisal of each piece of evidence in preparation for evidence synthesis. The table headers indicate important elements of each article that will contribute to the synthesis process. The data in each cell should be complete enough that the other team members can gather all relevant information related to the evidence without having to go to each source article.
**See Chapter 11, Lessons from Practice, for examples of completed tools.**
**Reviewer name(s):**
Record the member(s) of the team who are providing the information for each article. This will provide tracking if there are follow-up items or additional questions on an individual piece of evidence.
**Article number:**
Assign a number to each piece of evidence included in the table. This organizes the individual evidence summary and provides an easy way to reference articles.
**Author, date, and title:**
Record the last name of the first author of the article, the publication/communication date, and the title. This will help track articles throughout the literature search, screening, and review process. It is also helpful when someone has authored more than one publication included in the review.
**Type of evidence:**
Indicate the type of evidence for each source. This should be descriptive of the study or project design (e.g., randomized control trial, meta-analysis, mixed methods, qualitative, systematic review, case study, literature review) and not simply the level on the evidence hierarchy.
**Population, size, and setting:**
For research evidence, provide a quick view of the population, number of participants, and study location. For non-research evidence, population refers to the target audience, patient population, or profession. Non-research evidence may or may not have a sample size and/or location as found with research evidence.
**Intervention:**
Record the intervention(s) implemented or discussed in the article. This should relate to the intervention or comparison elements of your PICO question.
**Findings that help answer the EBP question:**
List findings from the article that directly answer the EBP question. These should be succinct statements that provide enough information that the reader does not need to return to the original article. Avoid directly copying and pasting from the article.
**Measures used**:
These are the measures and/or instruments (e.g., counts, rates, satisfaction surveys, validated tools, subscales) the authors used to determine the answer to the research question or the effectiveness of their intervention. Consider these measures as identified in the evidence for collection during the implementation of the EBP team’s project.
**Limitations:**
Provide the limitations of the evidence—both as listed by the authors as well as your assessment of any flaws or drawbacks. Consider the methodology, quality of reporting, and generalizability to the population of interest. Limitations should be apparent from the team’s appraisals using the Research and Non-Research Evidence Appraisal Tools (Appendices E and F). It can be helpful to consider the reasons an article did not receive a “high” quality rating because these reasons are limitations identified by the team.
**Evidence level and quality:**
Using the Research and Non-Research Evidence Appraisal tools (Appendices E and F), record the level (I-V) and quality (A, B or C) of the evidence. When possible, at least two reviewers should determine the level and quality.
**Notes to team:**
The team uses this section to keep track of items important to the EBP process not captured elsewhere on this tool. Consider items that will be helpful to have easy reference to when conducting the evidence synthesis.
© 2021 Johns Hopkins Health System/Johns Hopkins School of Nursing Page |
**1**
© 2022 Johns Hopkins Health System/Johns Hopkins School of Nursing Page |
**3**
## image1.jpeg
**AppendixH.docx**
This file is too large to display. [View in new window](https://www.sweetstudy.com/files/appendixh-docx-10431115)
**AppendixFNonresearchEvidenceAppraisal.docx**
This file is too large to display. [View in new window](https://www.sweetstudy.com/files/appendixfnonresearchevidenceappraisal-docx-10431111)
**AppendixEResearchEvidenceAppraisal.docx**
This file is too large to display. [View in new window](https://www.sweetstudy.com/files/appendixeresearchevidenceappraisal-docx-10431109)
**AppendixEResearchEvidenceAppraisal.docx**
This file is too large to display. [View in new window](https://www.sweetstudy.com/files/appendixeresearchevidenceappraisal-docx-10431109)
**## AppendixGIndividualEvidenceSummary.docx**
Johns Hopkins Evidence-Based Practice Model for Nursing and Healthcare Professionals
Individual Evidence Summary Tool
Appendix G
Johns Hopkins Nursing Evidence-Based Practice
Individual Evidence Summary Tool (Appendix G)
| | | | | | | | | | | |
| — | — | — | — | — | — | — | — | — | — | — |
| ## **EBP Question:** |
| ## **Reviewer name(s)** | ## **Article number** | ## **Author, date, and title** | ## **Type of evidence** | ## **Population, size, and setting** | ## **Intervention** | ## **Findings that help answer the EBP question** | ## **Measures used** | ## **Limitations** | ## **Evidence level and quality** | ## **Notes to team** |
| | | | | | | | | | | |
| | | | | | | | | | | |
| | | | | | | | | | | |
| | | | | | | | | | | |
| | | | | | | | | | | |
| | | | | | | | | | | |
| | | | | | | | | | | |
**Directions for use of the Individual Evidence Summary Tool**
**Purpose:** Use this form to document and collate the results of the review and appraisal of each piece of evidence in preparation for evidence synthesis. The table headers indicate important elements of each article that will contribute to the synthesis process. The data in each cell should be complete enough that the other team members can gather all relevant information related to the evidence without having to go to each source article.
**See Chapter 11, Lessons from Practice, for examples of completed tools.**
**Reviewer name(s):**
Record the member(s) of the team who are providing the information for each article. This will provide tracking if there are follow-up items or additional questions on an individual piece of evidence.
**Article number:**
Assign a number to each piece of evidence included in the table. This organizes the individual evidence summary and provides an easy way to reference articles.
**Author, date, and title:**
Record the last name of the first author of the article, the publication/communication date, and the title. This will help track articles throughout the literature search, screening, and review process. It is also helpful when someone has authored more than one publication included in the review.
**Type of evidence:**
Indicate the type of evidence for each source. This should be descriptive of the study or project design (e.g., randomized control trial, meta-analysis, mixed methods, qualitative, systematic review, case study, literature review) and not simply the level on the evidence hierarchy.
**Population, size, and setting:**
For research evidence, provide a quick view of the population, number of participants, and study location. For non-research evidence, population refers to the target audience, patient population, or profession. Non-research evidence may or may not have a sample size and/or location as found with research evidence.
**Intervention:**
Record the intervention(s) implemented or discussed in the article. This should relate to the intervention or comparison elements of your PICO question.
**Findings that help answer the EBP question:**
List findings from the article that directly answer the EBP question. These should be succinct statements that provide enough information that the reader does not need to return to the original article. Avoid directly copying and pasting from the article.
**Measures used**:
These are the measures and/or instruments (e.g., counts, rates, satisfaction surveys, validated tools, subscales) the authors used to determine the answer to the research question or the effectiveness of their intervention. Consider these measures as identified in the evidence for collection during the implementation of the EBP team’s project.
**Limitations:**
Provide the limitations of the evidence—both as listed by the authors as well as your assessment of any flaws or drawbacks. Consider the methodology, quality of reporting, and generalizability to the population of interest. Limitations should be apparent from the team’s appraisals using the Research and Non-Research Evidence Appraisal Tools (Appendices E and F). It can be helpful to consider the reasons an article did not receive a “high” quality rating because these reasons are limitations identified by the team.
**Evidence level and quality:**
Using the Research and Non-Research Evidence Appraisal tools (Appendices E and F), record the level (I-V) and quality (A, B or C) of the evidence. When possible, at least two reviewers should determine the level and quality.
**Notes to team:**
The team uses this section to keep track of items important to the EBP process not captured elsewhere on this tool. Consider items that will be helpful to have easy reference to when conducting the evidence synthesis.
© 2021 Johns Hopkins Health System/Johns Hopkins School of Nursing Page |
**1**
© 2022 Johns Hopkins Health System/Johns Hopkins School of Nursing Page |
**3**
## image1.jpeg
**AppendixH.docx**
This file is too large to display. [View in new window](https://www.sweetstudy.com/files/appendixh-docx-10431115)
**AppendixFNonresearchEvidenceAppraisal.docx**
This file is too large to display. [View in new window](https://www.sweetstudy.com/files/appendixfnonresearchevidenceappraisal-docx-10431111)
**AppendixEResearchEvidenceAppraisal.docx**
This file is too large to display. [View in new window](https://www.sweetstudy.com/files/appendixeresearchevidenceappraisal-docx-10431109)
**## AppendixGIndividualEvidenceSummary.docx**
Johns Hopkins Evidence-Based Practice Model for Nursing and Healthcare Professionals
Individual Evidence Summary Tool
Appendix G
Johns Hopkins Nursing Evidence-Based Practice
Individual Evidence Summary Tool (Appendix G)
| | | | | | | | | | | |
| — | — | — | — | — | — | — | — | — | — | — |
| ## **EBP Question:** |
| ## **Reviewer name(s)** | ## **Article number** | ## **Author, date, and title** | ## **Type of evidence** | ## **Population, size, and setting** | ## **Intervention** | ## **Findings that help answer the EBP question** | ## **Measures used** | ## **Limitations** | ## **Evidence level and quality** | ## **Notes to team** |
| | | | | | | | | | | |
| | | | | | | | | | | |
| | | | | | | | | | | |
| | | | | | | | | | | |
| | | | | | | | | | | |
| | | | | | | | | | | |
| | | | | | | | | | | |
**Directions for use of the Individual Evidence Summary Tool**
**Purpose:** Use this form to document and collate the results of the review and appraisal of each piece of evidence in preparation for evidence synthesis. The table headers indicate important elements of each article that will contribute to the synthesis process. The data in each cell should be complete enough that the other team members can gather all relevant information related to the evidence without having to go to each source article.
**See Chapter 11, Lessons from Practice, for examples of completed tools.**
**Reviewer name(s):**
Record the member(s) of the team who are providing the information for each article. This will provide tracking if there are follow-up items or additional questions on an individual piece of evidence.
**Article number:**
Assign a number to each piece of evidence included in the table. This organizes the individual evidence summary and provides an easy way to reference articles.
**Author, date, and title:**
Record the last name of the first author of the article, the publication/communication date, and the title. This will help track articles throughout the literature search, screening, and review process. It is also helpful when someone has authored more than one publication included in the review.
**Type of evidence:**
Indicate the type of evidence for each source. This should be descriptive of the study or project design (e.g., randomized control trial, meta-analysis, mixed methods, qualitative, systematic review, case study, literature review) and not simply the level on the evidence hierarchy.
**Population, size, and setting:**
For research evidence, provide a quick view of the population, number of participants, and study location. For non-research evidence, population refers to the target audience, patient population, or profession. Non-research evidence may or may not have a sample size and/or location as found with research evidence.
**Intervention:**
Record the intervention(s) implemented or discussed in the article. This should relate to the intervention or comparison elements of your PICO question.
**Findings that help answer the EBP question:**
List findings from the article that directly answer the EBP question. These should be succinct statements that provide enough information that the reader does not need to return to the original article. Avoid directly copying and pasting from the article.
**Measures used**:
These are the measures and/or instruments (e.g., counts, rates, satisfaction surveys, validated tools, subscales) the authors used to determine the answer to the research question or the effectiveness of their intervention. Consider these measures as identified in the evidence for collection during the implementation of the EBP team’s project.
**Limitations:**
Provide the limitations of the evidence—both as listed by the authors as well as your assessment of any flaws or drawbacks. Consider the methodology, quality of reporting, and generalizability to the population of interest. Limitations should be apparent from the team’s appraisals using the Research and Non-Research Evidence Appraisal Tools (Appendices E and F). It can be helpful to consider the reasons an article did not receive a “high” quality rating because these reasons are limitations identified by the team.
**Evidence level and quality:**
Using the Research and Non-Research Evidence Appraisal tools (Appendices E and F), record the level (I-V) and quality (A, B or C) of the evidence. When possible, at least two reviewers should determine the level and quality.
**Notes to team:**
The team uses this section to keep track of items important to the EBP process not captured elsewhere on this tool. Consider items that will be helpful to have easy reference to when conducting the evidence synthesis.
© 2021 Johns Hopkins Health System/Johns Hopkins School of Nursing Page |
**1**
© 2022 Johns Hopkins Health System/Johns Hopkins School of Nursing Page |
**3**
## image1.jpeg
**AppendixH.docx**
This file is too large to display. [View in new window](https://www.sweetstudy.com/files/appendixh-docx-10431115)
**AppendixFNonresearchEvidenceAppraisal.docx**
This file is too large to display. [View in new window](https://www.sweetstudy.com/files/appendixfnonresearchevidenceappraisal-docx-10431111)
**AppendixEResearchEvidenceAppraisal.docx**
This file is too large to display. [View in new window](https://www.sweetstudy.com/files/appendixeresearchevidenceappraisal-docx-10431109)
– 1
– 2
– 3
– 4
– ## NUR5141assignment.docx **## NUR5141assignment.docx** **_United States Preventive Service Taskforce (USPSTF)_** Following the guidelines of the United States Preventive Service Taskforce (USPSTF), discuss and describe the screening recommendations for the following: · Cervical cancer · Breast ca…
Immediate access to the full model answer, formatted citations, and rubric breakdown.
Have this question answered from scratch according to your specific instructions and deadline.
Order on TutorsGallery →– ## NUR5141assignment.docx
**## NUR5141assignment.docx**
**_United States Preventive Service Taskforce (USPSTF)_**
Following the guidelines of the United States Preventive Service Taskforce (USPSTF), discuss and describe the screening recommendations for the following:
· Cervical cancer
· Breast cancer
· Osteoporosis
· Colorectal cancer
· Lung cancer
· Ovarian cancer
· Intimate partner violence (IPV).
**Submission Instructions:**
· The paper is to be clear and concise and students will lose points for improper grammar, punctuation and misspelling.
· The paper is to be no shorter than 3-4 pages in length, excluding the title and references page.
· Your paper should be formatted per APA.
· Your submission will be reviewed for plagiarism through Turnitin.
· Incorporate current practice guidelines for diagnosis and treatment and a minimum of 4 current (published within the last five years) scholarly journal articles or primary legal sources (statutes, court opinions) within your work. Journal articles and books should be referenced according to APA style (the library has a copy of the APA Manual).
**## NUR5141assignment.docx**
**_United States Preventive Service Taskforce (USPSTF)_**
Following the guidelines of the United States Preventive Service Taskforce (USPSTF), discuss and describe the screening recommendations for the following:
· Cervical cancer
· Breast cancer
· Osteoporosis
· Colorectal cancer
· Lung cancer
· Ovarian cancer
· Intimate partner violence (IPV).
**Submission Instructions:**
· The paper is to be clear and concise and students will lose points for improper grammar, punctuation and misspelling.
· The paper is to be no shorter than 3-4 pages in length, excluding the title and references page.
· Your paper should be formatted per APA.
· Your submission will be reviewed for plagiarism through Turnitin.
· Incorporate current practice guidelines for diagnosis and treatment and a minimum of 4 current (published within the last five years) scholarly journal articles or primary legal sources (statutes, court opinions) within your work. Journal articles and books should be referenced according to APA style (the library has a copy of the APA Manual).
From the questionnaire [“Prevaccination Checklist for COVID-19 Vaccines”](https://agmu.instructure.com/courses/43007/files/10979598?wrap=1 "HESC 700 Module 2 The Studies.docx") [ATTACHED ,“Prevaccination Checklist for COVID-19 Vaccines”](https://agmu.instructure.com/courses/43007/files/10979598/down…
Immediate access to the full model answer, formatted citations, and rubric breakdown.
Have this question answered from scratch according to your specific instructions and deadline.
Order on TutorsGallery →From the questionnaire [“Prevaccination Checklist for COVID-19 Vaccines”](https://agmu.instructure.com/courses/43007/files/10979598?wrap=1 "HESC 700 Module 2 The Studies.docx") [ATTACHED ,“Prevaccination Checklist for COVID-19 Vaccines”](https://agmu.instructure.com/courses/43007/files/10979598/download?download_frd=1)(Module 2), Table 1, select the most appropriate method to display the frequency of patients presenting with the four questions shown in the table. With the same information (COVID-19), prepare a bar graph for the percentage of (yes) (no) answers from the total responses equaling (24).
**Submission Instructions:**
– It should include at least 2 academic sources, formatted and cited in APA within the past 5 year
– LESS THAN 10% PLAGIARISM OR AI TEXT PLEASE WILL BE SUBMITTED VIA TURNIN IN
– DUE DATE OCT 22, 2025
– 1 PAGE.
\
PRE-VACCINATIONCHECKLISTANDRUBRIC.pdf](https://www.sweetstudy.com/files/pre-vaccinationchecklistandrubric-pdf "PRE-VACCINATIONCHECKLISTANDRUBRIC.pdf")
\
PLAGIOREPORT3.pdf](https://www.sweetstudy.com/files/plagioreport3-pdf "PLAGIOREPORT3.pdf")
From the questionnaire [“Prevaccination Checklist for COVID-19 Vaccines”](https://agmu.instructure.com/courses/43007/files/10979598?wrap=1) [ATTACHED ,“Prevaccination Checklist for COVID-19 Vaccines”](https://agmu.instructure.com/courses/43007/files/10979598/download?download_frd=1)(Module 2), Table…
Immediate access to the full model answer, formatted citations, and rubric breakdown.
Have this question answered from scratch according to your specific instructions and deadline.
Order on TutorsGallery →From the questionnaire [“Prevaccination Checklist for COVID-19 Vaccines”](https://agmu.instructure.com/courses/43007/files/10979598?wrap=1) [ATTACHED ,“Prevaccination Checklist for COVID-19 Vaccines”](https://agmu.instructure.com/courses/43007/files/10979598/download?download_frd=1)(Module 2), Table 1, select the most appropriate method to display the frequency of patients presenting with the four questions shown in the table. With the same information (COVID-19), prepare a bar graph for the percentage of (yes) (no) answers from the total responses equaling (24). **Submission Instructions:**
– It should include at least 2 academic sources, formatted and cited in APA within the past 5 year
– LESS THAN 10% PLAGIARISM OR AI TEXT PLEASE WILL BE SUBMITTED VIA TURNIN IN
– DUE DATE OCT 22, 2025
– 1 PAGE.
\
PRE-VACCINATIONCHECKLISTANDRUBRIC.pdf](https://www.sweetstudy.com/files/pre-vaccinationchecklistandrubric-pdf-10431001 "PRE-VACCINATIONCHECKLISTANDRUBRIC.pdf")